MF

Marion Ferguson

EA To CEO at MEI Pharma

Marion Ferguson has a diverse work experience in the field of executive assistance. Their most recent role was as an Executive Assistant to the CEO at MEI Pharma, a clinical-stage pharmaceutical company. In this role, they supported the CEO and acted as a liaison to the Board of Directors.

Prior to that, Marion worked as an Executive Assistant to the Chief Executive Officer at Respivant Sciences. Marion provided executive assistant support to five executive leaders and ensured excellent communication and time management within the team. Marion also planned various offsite events for the company.

Before joining Respivant Sciences, Marion was an Executive Assistant to the Chief Executive Officer at Regulus Therapeutics. In this role, they acted as a liaison for board communications, arranged quarterly meetings and offsite events, and developed strong relationships with investment bankers.

Marion also gained experience as an Executive Assistant to the Chairman, President, and CEO at StemmImmune Inc., where they built a fully functioning office for a start-up company and oversaw various administrative tasks.

Their earliest work experience was as an Executive Administrative Assistant Office Manager at Celladon Corporation. Marion supported multiple Life Science companies and eventually transitioned to solely supporting Celladon. Marion provided executive administrative support to the CEO, managed calendars and extensive travel schedules, and gained experience with the company's IPO announcement.

Overall, Marion Ferguson has a strong background in executive assistance, with experience in various industries and a demonstrated ability to support high-level executives.

Marion Ferguson has a Small Business Diploma in Business Administration from Loughton College in Essex, England. Marion also attended Nightingale High School in London, England, although it is not specified whether they obtained a degree or studied a particular field.

Links

Previous companies

Regulus Therapeutics logo

Timeline

  • EA To CEO

    February, 2021 - present

View in org chart